AIRE and autoimmune polyendocrine syndrome type 1: Because clinical and experimental findings suggest that different AIRE mutations have different impact on AIRE function and activity (e.g. from complete loss of function to residual activity) (39, 40), differential expression analysis was also performed using only the subset of APS-1 patients (n=5) with the 13bp deletion mutation, the most common mutation in the dataset.